(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
5 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 11.07%
@ $8.96
Issued: 3 May 2024 @ 14:02
Return: 2.12%
Previous signal: May 3 - 11:22
Previous signal:
Return: -3.66 %
Live Chart Being Loaded With Signals
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems...
Stats | |
---|---|
Today's Volume | 14.61M |
Average Volume | 6.86M |
Market Cap | 6.19B |
EPS | $-0.350 ( 2024-03-20 ) |
Next earnings date | ( $-0.160 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.96 |
ATR14 | $1.360 (14.77%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-22 | Simon Barry J. | Buy | 159 146 | Stock Option (right to buy) |
2024-02-22 | Simon Barry J. | Buy | 45 731 | Restricted Stock Units |
2024-02-22 | Lauer Regan J | Buy | 42 439 | Stock Option (right to buy) |
2024-02-22 | Lauer Regan J | Buy | 12 195 | Restricted Stock Units |
2024-02-22 | Sachs David C. | Buy | 424 390 | Stock Option (right to buy) |
INSIDER POWER |
---|
99.24 |
Last 97 transactions |
Buy: 228 380 025 | Sell: 921 083 |
Volume Correlation
ImmunityBio, Inc. Correlation
10 Most Positive Correlations | |
---|---|
SIRI | 0.928 |
RGF | 0.928 |
FGBI | 0.925 |
AROW | 0.921 |
ALRS | 0.92 |
GNTY | 0.92 |
CBNK | 0.915 |
GSMG | 0.914 |
GOOD | 0.906 |
ALLK | 0.906 |
10 Most Negative Correlations | |
---|---|
RIVE | -0.933 |
DSEY | -0.93 |
DUOL | -0.927 |
AMPH | -0.926 |
RAM | -0.919 |
INTA | -0.919 |
PLYA | -0.918 |
ALTR | -0.91 |
DAIO | -0.909 |
MLTX | -0.907 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
ImmunityBio, Inc. Correlation - Currency/Commodity
ImmunityBio, Inc. Financials
Annual | 2023 |
Revenue: | $622 000 |
Gross Profit: | $-17.89M (-2 876.21 %) |
EPS: | $-1.150 |
FY | 2023 |
Revenue: | $622 000 |
Gross Profit: | $-17.89M (-2 876.21 %) |
EPS: | $-1.150 |
FY | 2022 |
Revenue: | $240 000 |
Gross Profit: | $-23.95M (-9 980.00 %) |
EPS: | $-1.040 |
FY | 2021 |
Revenue: | $934 000 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.893 |
Financial Reports:
No articles found.
ImmunityBio, Inc.
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amyris, Inc.; and license agreements with CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., and Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company was founded in 2014 and is based in San Diego, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators